1.
Jädersten M, Saft L, Pellagatti A, Göhring G, Wainscoat JS, Boultwood J, Porwit A, Schlegelberger B, Hellström-Lindberg E. Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression. Haematologica [Internet]. 2009Dec.7 [cited 2026Nov.18];94(12):1762-6. Available from: https://haematologica.org/article/view/5444